The release date for clinical quality measure specifications under the proposed Stage 2 meaningful use criteria does not provide enough lead time for review, development and certification efforts by vendors, and implementation by providers, according to the Healthcare Information and Management Systems Society.

“This presents a significant risk to patient safety,” HIMSS contends in a comment letter to the Centers for Medicare and Medicaid Services. Seventy-nine of the proposed measures for Stage 2 don’t have final electronic specifications to support comment on whether they are feasible and can be efficiently implemented, the letter notes.

Register or login for access to this item and much more

All Health Data Management content is archived after seven days.

Community members receive:
  • All recent and archived articles
  • Conference offers and updates
  • A full menu of enewsletter options
  • Web seminars, white papers, ebooks

Don't have an account? Register for Free Unlimited Access